Shara RosenArtificial IntelligenceClinical diagnostics and the artificial intelligence boomWhile AI skeptics believe that nothing can replace human experience in the interpretation of test data, proponents of AI point to the many benefits that the technology -- in all its forms -- has brought to the diagnostics arena, including workplace efficiencies and improved diagnostics.March 22, 2020Swine FluAs COVID-19 crisis continues, other infectious diseases threatenAs of March 16, the World Health Organization (WHO) had reported more than 137,000 confirmed cases and over 6,600 deaths worldwide from COVID-19, the respiratory disease caused by the SARS-CoV-2 virus. The diagnostics industry is rising to the challenge presented by the coronavirus pandemic, with test developers creating new assays to detect SARS-CoV-2 infection as lab operators ramp up throughput to meet skyrocketing demand.March 17, 2020Page 1 of 1Top StoriesFinancial ResultsCue Health Q4 revenues decline 24% as firm expands, diversifies POC test menuThe company’s revenues have come predominantly from its COVID-19 testing product, but it is "executing well" on its strategy of expanding the test menu, CEO Ayub Khattak said.Pancreatic CancerDuke University researchers discover biomarkers may identify early pancreatic cancer riskRare DiseaseGenetic causes identified for three rare diseasesTechnology DevelopmentAmplified Sciences developing dye-based tests for early detection of pancreatic cancerSequencingBionano Laboratories launches new optical genome mapping tests
